Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95


The Role of Genetic Testing in the Identification of Young Athletes with Inherited Primitive Cardiac Disorders at Risk of Exercise Sudden Death.

Tiziano FD, Palmieri V, Genuardi M, Zeppilli P.

Front Cardiovasc Med. 2016 Aug 26;3:28. doi: 10.3389/fcvm.2016.00028. Review.


Echocardiographic diagnosis of the different phenotypes of hypertrophic cardiomyopathy.

Parato VM, Antoncecchi V, Sozzi F, Marazia S, Zito A, Maiello M, Palmiero P; Italian Chapter of ISCU..

Cardiovasc Ultrasound. 2016 Aug 12;14(1):30. doi: 10.1186/s12947-016-0072-5. Review.


Factors Contributing to Development and Reversal of LVH: A Pilot Study.

Ramaswamy PK, Bhanukumar M, Hathur B, Shashidhara KC, Srinath KM.

J Clin Diagn Res. 2016 May;10(5):OC17-20. doi: 10.7860/JCDR/2016/19747.7767.


Longitudinal strain bull's eye plot patterns in patients with cardiomyopathy and concentric left ventricular hypertrophy.

Liu D, Hu K, Nordbeck P, Ertl G, Störk S, Weidemann F.

Eur J Med Res. 2016 May 10;21(1):21. doi: 10.1186/s40001-016-0216-y. Review.


Left Ventricular Hypertrophy in Rhesus Macaques (Macaca mulatta) at the California National Primate Research Center (1992-2014).

Reader JR, Canfield DR, Lane JF, Kanthaswamy S, Ardeshir A, Allen AM, Tarara RP.

Comp Med. 2016 Apr;66(2):162-9.


Cardiovascular magnetic resonance demonstration of the spectrum of morphological phenotypes and patterns of myocardial scarring in Anderson-Fabry disease.

Deva DP, Hanneman K, Li Q, Ng MY, Wasim S, Morel C, Iwanochko RM, Thavendiranathan P, Crean AM.

J Cardiovasc Magn Reson. 2016 Mar 31;18:14. doi: 10.1186/s12968-016-0233-6.


Clinical Spectrum of PRKAG2 Syndrome.

Porto AG, Brun F, Severini GM, Losurdo P, Fabris E, Taylor MR, Mestroni L, Sinagra G.

Circ Arrhythm Electrophysiol. 2016 Jan;9(1):e003121. doi: 10.1161/CIRCEP.115.003121. Review. No abstract available.


Diagnosis and management of hypertrophic cardiomyopathy.

Pantazis A, Vischer AS, Perez-Tome MC, Castelletti S.

Echo Res Pract. 2015 Mar 1;2(1):R45-53. doi: 10.1530/ERP-15-0007. Review.


Renal Denervation Findings on Cardiac and Renal Fibrosis in Rats with Isoproterenol Induced Cardiomyopathy.

Liu Q, Zhang Q, Wang K, Wang S, Lu D, Li Z, Geng J, Fang P, Wang Y, Shan Q.

Sci Rep. 2015 Dec 22;5:18582. doi: 10.1038/srep18582.


Proteomic analysis of physiological versus pathological cardiac remodeling in animal models expressing mutations in myosin essential light chains.

Gomes AV, Kazmierczak K, Cheah JX, Gilda JE, Yuan CC, Zhou Z, Szczesna-Cordary D.

J Muscle Res Cell Motil. 2015 Dec;36(6):447-61. doi: 10.1007/s10974-015-9434-0.


Cardiac sympathetic activity in hypertrophic cardiomyopathy and Tako-tsubo cardiomyopathy.

Verschure DO, van Eck-Smit BL, Somsen GA, Verberne HJ.

Clin Transl Imaging. 2015;3(5):379-385. Review.


Comparison of Outcomes in Patients With Nonobstructive, Labile-Obstructive, and Chronically Obstructive Hypertrophic Cardiomyopathy.

Pozios I, Corona-Villalobos C, Sorensen LL, Bravo PE, Canepa M, Pisanello C, Pinheiro A, Dimaano VL, Luo H, Dardari Z, Zhou X, Kamel I, Zimmerman SL, Bluemke DA, Abraham MR, Abraham TP.

Am J Cardiol. 2015 Sep 15;116(6):938-44. doi: 10.1016/j.amjcard.2015.06.018.


Sudden adult death syndrome in m.3243A>G-related mitochondrial disease: an unrecognized clinical entity in young, asymptomatic adults.

Ng YS, Grady JP, Lax NZ, Bourke JP, Alston CL, Hardy SA, Falkous G, Schaefer AG, Radunovic A, Mohiddin SA, Ralph M, Alhakim A, Taylor RW, McFarland R, Turnbull DM, Gorman GS.

Eur Heart J. 2016 Aug 21;37(32):2552-9. doi: 10.1093/eurheartj/ehv306.


Rest perfusion abnormalities in hypertrophic cardiomyopathy: correlation with myocardial fibrosis and risk factors for sudden cardiac death.

Chiribiri A, Leuzzi S, Conte MR, Bongioanni S, Bratis K, Olivotti L, De Rosa C, Lardone E, Di Donna P, Villa AD, Cesarani F, Nagel E, Gaita F, Bonamini R.

Clin Radiol. 2015 May;70(5):495-501. doi: 10.1016/j.crad.2014.12.018.


Pattern and degree of left ventricular remodeling following a tailored surgical approach for hypertrophic obstructive cardiomyopathy.

El-Hamamsy I, Lekadir K, Olivotto I, El Guindy A, Merrifield R, Rega L, Yang G, Cecchi F, Yacoub MH.

Glob Cardiol Sci Pract. 2012 Jul 3;2012(1):9. doi: 10.5339/gcsp.2012.9.


Hypertrophic cardiomyopathy: Can the noninvasive diagnostic testing identify high risk patients?

Zhang L, Mmagu O, Liu L, Li D, Fan Y, Baranchuk A, Kowey PR.

World J Cardiol. 2014 Aug 26;6(8):764-70. doi: 10.4330/wjc.v6.i8.764. Review.


Sudden cardiac death in patients with nonischemic cardiomyopathy.

Betensky BP, Dixit S.

Indian Heart J. 2014 Jan-Feb;66 Suppl 1:S35-45. doi: 10.1016/j.ihj.2013.12.047. Review.


Recurrent syncope episodes and exercise intolerance in hypertrophic cardiomyopathy combined with atrioventricular conduction disturbance.

Kim KH, Yang DH, Kim CY, Kim NK, Choi WS, Bae MH, Lee JH, Park HS, Cho Y, Chae SC.

J Cardiovasc Ultrasound. 2013 Sep;21(3):148-51. doi: 10.4250/jcu.2013.21.3.148.


Use of a highly-sensitive cardiac troponin I assay in a screening population for hypertrophic cardiomyopathy: a case-referent study.

McGorrian CM, Lyster S, Roy A, Tarrant H, Codd M, Doran P, Fitzgibbon M, Galvin J, Mahon NG.

BMC Cardiovasc Disord. 2013 Sep 11;13:70. doi: 10.1186/1471-2261-13-70.

Items per page

Supplemental Content

Support Center